Clinical trial · Interventional
Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Evaluation of the Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China. The main questions it aims to answer are: * Does the intervention alleviate participants' financial toxicity? * Does the intervention enhance participants' cost-related health literacy? * Does the intervention improve participants' shared decision-making? * Does the intervention reduce participants' perceived stress? Researchers will compare the financial navigation program with usual oncology care to evaluate its effectiveness. Participants will receive the comprehensive financial navigation, including: * Needs assessment; * Cost-related health education, mainly including topics regarding communication of cost, treatment-related cost, health insurance policies, and family support; * Resource and service referral; * Personalized counseling.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm Female | — | UNRESOLVED | — |
| Financial Navigation | — | UNRESOLVED | — |
| Financial Toxicity | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Financial Navigation | Behavioral | — | UNRESOLVED |
| Usual Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Financial Navigation
- description
- Participants will receive financial navigation service, including * Needs Assessment: provide a brief introduction of cancer-related FT and assess patients' information needs using a self-made cost-related health literacy questionnaire; * Cost-Related Health Education: mainly include topics regarding communication of cost, treatment-related cost, health insurance policies, and family support; * Resource and Service Referral: promote timely referral to financial assistance programs and clinical professionals when identify unaddressed problems; * Personalized Counseling Module: provide one-on-one counseling for symptom management, cost-related issues, and coping strategies.
- interventionNames
- Behavioral: Financial Navigation
- type
- ACTIVE_COMPARATOR
- label
- Usual Care
- description
- Participants will receive usual care during hospitalization and regular follow-up after discharge. Participants have the freedom to utilize any financial resources, but financial navigators do not offer comprehensive information support. When participants actively inquire about cancer treatment-related costs or financial planning strategies, financial navigators will answer their questions.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed with breast cancer and undergoing surgery during this admission; * Female, age 18 years or older; * Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy; * Eastern Cooperative Oncology Group Performance Status 0-2; * Provided informed consent to participate in this study. Exclusion Criteria: * Diagnosed with ductal carcinoma in situ (DCIS) * Presence of any serious psychiatric disorders; * Cognitive impairments; * Difficulty in reading, writing, or communicating in Chinese.
References
Publications (1)
- DERIVEDJing F, Yuan X, Tang Y, Liu Y, Huang Y, Chen L, Tang L, Qiu J, Xing W. The effects of a financial navigation intervention on financial toxicity among patients with breast cancer in China: A randomized controlled trial. Breast. 2026 Aug;88:104824. doi: 10.1016/j.breast.2026.104824. Epub 2026 May 27. PMID 42224905